org placeholder image

Kevin Mannix

SVP, Investor Relations & Corporate Communications at Seres Therapeutics

  • LinkedIn

Email Email: k****@tevapharm.com

phone noPhone Number: (***)-***-****

map
SERES THERAPEUTICS

SERES THERAPEUTICS

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Seres Therapeutics Org Chart and Mapping

Eric Shaff

President, Chief Executive Officer

VP-Level

Kevin Mannix

SVP, Investor Relations & Corporate Communications

Employees

Kimberly West

Associate I, Donor Analytical Sciences

Naeem Sarwar

Director - Qc Raw Materials

Kelly Wilkerson

Associate Director, Clinical Operations, Clinical Research Liaison

Nicolas Cicolini

Cyber Operations, Analyst II

Nick Ventresca

Chief Information Officer

Kristen Grogan

Senior Director, Legal & Compliance Operations

Frequently Asked Questions Regarding Kevin Mannix

Answer: Kevin Mannix works for Seres Therapeutics as SVP, Investor Relations & Corporate Communications

Answer: Kevin Mannix’s role in Seres Therapeutics is SVP, Investor Relations & Corporate Communications

Answer: Kevin Mannix's email address is k***@gmail.com

Answer: Kevin Mannix's business email address is k****@tevapharm.com

Answer: Kevin Mannix’s direct phone number is (***)-***-****

Answer: Kevin Mannix works in the industry of: Biotechnology

Answer: Kevin Mannix works Seres Therapeutics located at 200 Sidney St Fl 4, Cambridge, Massachusetts, 02139, United States

Answer: Seres Therapeutics's SVP, Investor Relations & Corporate Communications is Kevin Mannix

Answer: Kevin Mannix contact details:

  • Phone number  :  (***)-***-****
  • Email  :  k****@tevapharm.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access